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ABSTRACT: 
 
Background:   Surgery in paediatric patients is a stress to both parents and the  
children. The fear and anxiety originates mainly from the fear of needle pricks and  
separation of the children from their parents, to be taken away by strangers with  
mask and cap. So premedication to cause sedation and anxiolysis is a must.A  
prospective double blinded randomized clinical trial was conducted to compare  
oral triclofos and midazolam. 
 
Aim of the study: The main objective is to compare the sedative effects of oral  
triclofos with oral midazolam when used as premedicants in paediatric patients for  
day care surgery. The study also focused on the drug acceptance, parental  
separation and mask acceptance at induction of anaesthesia. 
 
Materials and methods: 150 children in the age group of 2-9 years, belonging to  
ASA 1 status were randomly assigned into two groups, Tand  M with 75 children  
in each group and received Triclofos 75mg/kg and  Midazolam 0.5mg/kg  orally 45  
minutes before surgery.The preoperative sedation scores were assessed at repeated  
intervals. The parent separation score was assessed  at the shifting of  the children  
to the operation room. The mask acceptance score  at induction of anaesthesia was  
also noted. The postoperative sedation score was assessed  for the next 6 hours  
postoperatively and the difference in the two groups noted. 
 
Results: 
         Triclofos was accepted   better by the children than midazolam ,  produced  
higher sedation levels when given in the dose of 75mg/kg after 45 minutes of 
administration than midazolam 0.5mg/kg. Hemodynamic variables were 
comparable in the two groups. Though the parental separation score was 
comparable between the two groups, Triclofos  provided  good mask acceptance 
and postoperative recovery. 
 
Conclusion: 
        Triclofos  is a better and safe sedative premedicant  than midazolam in 
paediatric patients. 
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RANDOMISED  CLINICAL  TRIAL TO  COMPARE  THE 
SEDATIVE EFFECTS  OF  ORAL  TRICLOFOS  AND  ORAL  
MIDAZOLAM  AS PREMEDICANTS  IN  CHILDREN 
INTRODUCTION: 
      Surgery in paediatric age group is a great stress to both the parents 
and the  children. The feeling of fear, anxiety and insecurity is mainly due 
to the separation  of the child from the parent and also the encounter of 
strangers with mask and  caps. Moreover children are also apprehensive 
of the needle prick and a mask  that puts them in a state of doom. So to 
calm down the child and to obtain their co-operation during parent 
separation, a premedicant is necessary. Various forms of  premedicant 
drugs are available like oral formulations, nasal spray, sublingual 
preparations, intramuscular injections, rectal suppositories etc. Out of 
these oral formulation is more easier and simpler to administer to 
children. Children are more compliant with the oral formulations which 
are usually prepared as flavored syrup making it acceptable by the 
children. 
         Out of the commonly used premedicant drugs, oral triclofos and 
oral  midazolam are better sedatives and free of major adverse effects. So 
this study is  conducted to study the sedative effects of both these  drugs; 
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also the adverse effects and the anxiolytic effects will be compared. 
These drugs leave the child sedated and withdrawn from surroundings 
which allows a calm child entering the theatre instead of a crying and 
agitated child. These drugs also have the advantage of  short duration of 
action so that the child can be discharged on the same day.  So these 
drugs are being used predominantly in daycare surgeries. 
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Aim of the study: 
        To compare the sedative effects of oral triclofos and oral midazolam 
as a premedicant in children. 
 
Secondary objective: 
             To compare the drug compliance, parent separation score and 
mask acceptance score of oral triclofos and oral midazolam. 
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PREMEDICATION  IN  CHILDREN: 
Premedication is used in children not only to cause amnesia but 
also to allay the fear and anxiety from their minds. Parental separation in 
such a stressful situation like surgery makes them more restless and 
violent. The need for children to be in an unaccustomed place and 
situation, under the care of  strangers during  surgery is the main reason 
for all the hemodynamic responses and the psychological behavior 
disorders of the children. So premedication can be used to make them 
sleep and calm, make the child detached from the  surroundings in a state 
of deep sleep which takes away the fear from the children. Preoperative 
anxiety causes unpleasant experience for the patient and also makes the 
induction and recovery from anaesthesia more complicated.  
Premedication not only allays the anxieties about surgery, parent 
separation, the feel of pain, and about body disfigurement, but also allows 
a smoother and safer induction of  anaesthesia. 
Sedation can be defined as a state of drowsiness or sleep from 
which a subject  can be aroused whereas anaesthesia is an unarousable 
state in which vital respiratory reflexes may be lost. So  only conscious 
sedation is recommended as premedication. Using subanaesthetic doses 
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of anaesthetic drugs to cause sedation is  not advisable. So non 
anaesthetic  sedative drugs are preferred.  
        When selecting a premedication, three important factors which 
should  be  remembered are4: 
1. A  child’s major fear about hospitalization is because of  pain from  
needles and injections. For children, hospitalization is 
synonymous with needles. Children tend to remember the 
premedication injection more than the operative procedure pain. 
Thus any form other than intramuscular is preferred for 
premedication. 
2. Children with  frequent hospitalization   need  more preoperative 
medication than do the children coming for the first surgery. 
Experiences in the  previous hospitalization  forms the basis for 
their fears, so questions about the  past experiences are invaluable. 
The previous  anaesthetic record if available  should be reviewed, 
with careful attention  to the premedication agent used  and its 
effects. 
3. Premedication  effects in children vary producing different effects 
with some  children sedated,but some  excited and restless.  Few  
children may require about twice the recommended dose to 
produce desired level of sedation. 
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Some of the commonly used sedative drugs in children are as follows: 
Opioids: 
           Not preferred in infants younger than 6 months.  Premedication 
with opioid    may cause unpleasant dysphoria and  also  preoperative and 
postoperative vomiting.  Various  routes of  administration by which  
opioids can be given are oral, rectal, intravenous, intramuscular, and 
transmucosal  routes. Intranasal and oral transmucosal forms of  
administration has been  focused with interest in the recent years. 
Fentanyl    given in the dose of  0.5mcg/kg intravenously,  10 to 15   
mcg/kg oral  transmucosal.  
             Morphine     0.1-0.2 mg/kg  intramuscular 
             Meperidine   1-2 mg/kg  intramuscular 
             Sufentanil       1-3 mcg/kg  intranasal            
Benzodiazepines  : 
Midazolam is a water soluble benzodiazepine and has a rapid  
onset  and a shorter duration of   action. It is water soluble which is 
responsible for better absorption after intramuscular injection .Peak 
plasma concentration of  Midazolam  occurs  45 minutes after 
intramuscular injection, but the anxiolytic effects takes 5 to 60 minutes. 
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Its duration of action is usually 2 hours , ranging  from 1 to 6hours.It has 
been approved and marketed as an oral preparation recently,  and has 
become the most commonly administered premedication. Oral dose of 
midazolam is 0.25-0.75mg/kg. Intravenous preparation of midazolam can 
be given orally along with a vehicle like flavored syrup or fruit juices and 
has been proved effective in many studies26 . Nasal  midazolam is also 
reported to be highly effective in reducing anxiety in children by 10 to 12 
minutes of administration but the disadvantage of nasal midazolam is 
irritation of the nasal passages. Midazolam is also  administered 
sublingually (0.2 to 0.3 mg/kg) but difficult to prevent children from 
swallowing or spitting out immediately.  Rectal dose of midazolam is 0.5 
to 1 mg/kg. 
     Flunitrazepam  can be given as a rectal premedication in doses of  
0.04mg/kg.  Triazolam   reaches peak serum concentrations in 1 to 2 
hours due to short half  life; 0.02mg/kg orally is effective. 
         Diazepam  has greater fat solubility and  CNS effect than 
midazolam. Diazepam metabolized to desmethyldiazepam which is 
equally active pharmacologically like the parent compound.  It is given in 
the oral  dose of  0.3 to   0.5 mg/kg. It is not a preferred choice in children 
because of the  immature liver function. Diazepam is less effective when 
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administered rectally  than midazolam ; intramuscular administration is 
painful  and causes irritation. 
Barbiturates: 
       Only used rarely because of availability of short acting 
benzodiazipines. Methohexital has a relatively shorter half life, can be 
used rectally in the dose of  20 to 30 mg/kg and intramuscular in the dose 
of 10 mg/kg. This induces sedation in 15-20 minutes but has a 
unpredictable systemic absorption and possibility of  hypersensitivity. 
Side effects are hiccups, apnea, airway obstruction,  laryngospasm, 
seizures. Any rectal mucosal abnormality causes increased absorption of 
the drug leading to cardiac arrest. Methohexital is contraindicated in  
patients with porphyria, Temporal lobe Epilepsy and hypersensitivity. 
Barbiturates  have the disadvantage of hyperalgesia which may cause 
agitation in children due to pain. Thiopentone can be given rectally in the 
dose  20 to 40 mg/kg. 
Phencyclidine: 
Ketamine is a phencyclidine derivative which blocks the NMDA 
receptor.  Mechanism of action is by central dissociation of cortex from 
limbic   system, providing analgesia and sedation but  preserves the upper 
airway muscle  tone and respiratory drive.It is a bronchial smooth muscle 
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relaxant and used in cases of bronchospasm. Since it increases secretions 
, an antisialogogue has to be administered along with it. Hallucinations 
may occur at the time of recovery which can be avoided by co-
administration of a benzodiazepine.   Ketamine is not only  used for 
induction but also for maintenance of  anaesthesia in children. 
Intramuscular , oral , nasal transmucosal and rectal routes used for 
administration. Oral ketamine can be given alone or combined with oral 
midazolam.  Orally given as 3-6mg/kg, nasally 3mg/kg,rectally                      
6-10mg/kg and intramuscularly as 2-10 mg/kg. 
Chloral hydrate and triclofos: 
Chloral hydrate and triclofos  induce sedation effectively when 
given  orally. They are metabolised to trichlorethanol which cause drug 
residual effect and prolonged  sedation. Chloral hydrate tastes unpleasant   
and  also causes gastric irritation. Chloral hydrate   contraindicated in 
patients with liver disease because the  metabolism will be delayed which 
can lead to metabolic acidosis, renal failure and hypotonia. Airway 
obstruction and deaths  have also been reported. Though triclofos is more 
palatable, it is slower to act and also less potent than chloral hydrate. 
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Contraindications for sedation are:        Abnormal airway 
       Raised intracranial pressure 
          Depressed conscious level 
    History of sleep apnoea 
    Respiratory failure 
    Cardiac failure 
    Neuromuscular disease 
    Bowel obstruction 
    Active respiratory tract infection 
    Known allergy or adverse reaction to sedative 
    Child too distressed despite adequate preparation 
    Older child with severe behavioural problems 
                Consent refusal by parent or patient. 
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SCORING SYSTEMS: 
        Various sedation scores are  used worldwide . One  internationally 
accepted score is  Ramsay score: 
            
        Level                 Characteristics 
          1 patient awake, anxious, agitated or restless 
          2 patient awake, co-operative, oriented and tranquil 
          3 patient drowsy, with response to commands 
          4 patient asleep, brisk response to glabella tap or loud 
auditory stimulus 
         5 patient asleep, sluggish response to stimulus 
         6 patient has no response to firm nail bed pressure or 
other noxious stimuli 
                                      
            This score  was used in this study. 
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 PARENTAL SEPARATION SCORE: 
    Though many scores for separation from parents available, this is 
more easy and practical. 
       1 Calm and sleepy 
       2  Apprehensive but withdrawn from 
surroundings 
       3 Crying 
       4 Agitated but difficult to control 
   
This score was used in this study.         
FACE MASK ACCEPTANCE SCORE:    
  Four point score: 
    1 Poor Afraid, combative, crying 
   2 Fair Moderate fear of mask, not easily calmed 
   3 Good Slight fear of mask, easily calmed 
   4 Excellent Unafraid, cooperative, accepts mask easily 
 
The above score was used in the study. 
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Melatonin: 
      Induces natural  sleep successfully when given in doses ranging from 
2-10 mg  orally. 
Alpha agonists: 
Oral clonidine  premedication with  1 to 10 mcg/kg will produce a 
good sedation . Though oral clonidine possesses   several desirable 
aspects for  premedication , notably sedation and analgesia, the drug 
needs to be administered 60 minutes before induction, which is 
impractical  . Peak plasma concentration of clonidine occurs between 60 
to 90 minutes for oral formulation and 50minutes for rectal preparation. 
Newer drugs like alpha 2 agonists, have now emerged as alternatives for 
premedication .Dexmedetomidine a highly selective alpha 2 agonist has 
sedative and analgesic effects.It has limited effects on cardiorespiratory 
function. 
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PHARMACOLOGY 
 
MIDAZOLAM: 
STRUCTURE OF MIDAZOLAM: 
 
       
  
 
Introduction: 
        Midazolam was developed  by Hoffman-La-Roche in the 1970s. 
 Midazolam is a water soluble benzodiazepine. It has an imidazole ring  
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which contributes to the basicity, rapid metabolism and stability in 
aqueous  solution. It has replaced diazepam as a premedicant. Midazolam 
is a good amnestic and twice as potent as diazepam. It is available as a 
closed and  open structure which is pH dependent. It is available as a 
standard syrup preparation. 
Chemical  structure: 
8-Chloro - 6-(2- fluorophenyl) -1- methyl -4H- imidazo(1,5-α)(1,4)  
benzodiazepine  Hydrochloride 
Physical properties: 
    The pK of midazolam is 6.5, which permits preparation of salts that are  
soluble in water. Injectable solution buffered to acidic pH of 3.5. This is  
significant because the structure of midazolam whether open ring or 
closed  ring structure is dependent on the pH with the ring remaining 
open at pH < 4 , maintaining water solubility. The ring will close at pH 
>4, so  exposure  to physiological pH makes the drug highly lipid soluble 
. Basicity of the drug allows it to be mixed with salts like lactic acid, 
hydrochloric acid which  is responsible for the water solubility.The 
hydrochloride solution is better tolerated when given intravenously or 
intramuscularly. 
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         Water solubility obviates the need for a solubilising preparation 
such as propylene glycol which may interfere with absorption after 
intramuscular injection or may cause venoirritation when given 
intravenously. Midazolam is compatible with lactated Ringer solution and 
can be mixed with the acidic salts of other drugs including opioids and 
anticholinergics.  
Mechanism of  action: 
              Midazolam acts by facilitating   the effects  of gamma-
aminobutyric acid which is the inhibitory neurotransmitter  of the central 
nervous system. It  increases the affinity of the receptors for GABA 
instead of stimulating them resulting   in enhanced chloride gating 
channels opening causing  increased chloride conductance and  produces 
hyperpolarisation of the  postsynaptic cell membrane. There is resistance 
to excitation of the post synaptic  neurons  which is responsible for  
anxiolysis,  sedation, anterograde  amnesia and anti-convulsant effect. 
Pharmacokinetics: 
Midazolam undergoes rapid absorption from the gastrointestinal 
tract and passes promptly across the blood brain barrier, but has a slow 
effect site equilibration time. So intravenous doses should be spaced 
before a repeat  dose is to be administered. Only about 50% of the orally 
17 
 
given drug is \available in the systemic circulation because of a 
substantial first pass effect. 
Midazolam is extensively plasma protein bound.The  lipid 
solubility of midazolam  leads to rapid redistribution from the brain to 
other  inactive tissue sites because of which it is short acting. The 
elimination half-time is usually 1 to 4 hours;  but it may get doubled in 
geriatric patients which reflects age related decreases in hepatic blood 
flow. 
Metabolism: 
Midazolam is rapidly metabolized by cytochrome P-450 enzymes 
of the liver and small intestine to  both active and also inactive 
metabolites. The principal metabolite is 1-hydroxymidazolam; has 
approximately half the activity of the parent compound. This metabolite 
is conjugated to 1-hydroxymidazolam glucuronide and subsequently 
cleared by the kidneys. The glucuronide metabolite has substantial 
pharmacologic activity when present in high concentrations which may 
occur in critically ill patients with renal insufficiency receiving 
continuous intravenous infusions. 
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EFFECTS ON VARIOUS SYSTEMS: 
CENTRAL NERVOUS SYSTEM: 
Midazolam causes a reduced cerebral metabolic oxygen 
requirements and decreases cerebral blood flow. Cerebral vasomotor 
response to carbondioxide is preserved.  Midazolam  is a potent  
anticonvulsant  effective  in treatment of status epileptics. Parodoxical 
excitement occurs in <1%. 
RESPIRATORY SYSTEM: 
Midazolam produces dose dependent decrease in ventilation. When  
administered rapidly in large doses, that too with an opioid, transient 
apnea may occur .Also depresses the reflex  of swallowing and decrease 
upper airway activity. 
CARDIOVASCULAR SYSTEM: 
Midazolam produces a  decrease in systemic blood pressure and 
increase in heart rate. Cardiac output is not altered by midazolam. It does 
not  prevent blood pressure and heart rate responses evoked  by intubation 
of  the trachea. 
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CLINICAL USES:3 
Midazolam is the most widely used benzodiazepine for pre 
medication in paediatric patients, intravenous sedation, and induction of 
anaesthesia. 
PREOPERATIVE MEDICATION: 
Midazolam is the most often  used oral preoperative medication for  
Children. Oral midazolam syrup (2mg/ml) when given at a dose of 0.5 
mg/kg is effective for producing sedation  and anxiolysis with minimal 
effects on ventilation. When 0.5mg/kg  is administered orally 30 minutes 
before induction of anaesthesia , there is  reliable sedation and anxiolysis 
in children, that too without producing delayed awakening . 
INTRAVENOUS SEDATION: 
Midazolam when given intravenously  for sedation is effective 
during regional anaesthesia as well as for brief therapeutic procedures. 
Reduced hypoxic drive can lead to depressed ventilation  and it is the 
most significant side effect of midazolam which is exaggerated  when 
used along with  opioids and other CNS depressant drugs. 
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INDUCTION OF ANAESTHESIA: 
        Anaesthesia can be induced by the dose of 0.1 to 0.2 mg/kg iv, over 
30 to 60 seconds which is facilitated by  a small dose of opioid . 
MAINTENANCE OF ANAESTHESIA: 
Midazolam may be administered to supplement opioids , propofol 
and /or inhaled anaesthetics during maintenance of anaesthesia. 
POSTOPERATIVE SEDATION: 
Long term intravenous midazolam used for  sedation in intubated 
patients usually  results  in relative saturation of  the peripheral tissues 
with midazolam and clearance from the systemic circulation becomes less 
dependent on redistribution into peripheral tissues and more dependent on 
hepatic metabolism. Pharmacologically  active metabolites may 
accumulate with prolonged IV administration. 
CONTRAINDICATIONS: 
Hypersensitivity, acute narrow angle glaucoma, shock, hypotension 
or head injury. Kidney or liver disease may slow down the elimination 
leading to  prolonged  duration of action and exaggerated effects. 
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SIDE EFFECTS: 
1. Long term use is associated with deficits in memory. 
2. Depression may be worsened. 
3. With intravenous injections, paradoxical excitement can occur                
causing anxiety, involuntary movements, aggressive or violent  
behavior,    uncontrollable crying or verbalization. 
4. Sleepiness and impaired psychomotor and cognitive functions 
may  persist next day as hangover effects. 
5. Respiratory depression  hypotension and increased heart rate. 
TOLERANCE AND WITHDRAWAL: 
Use for more than 4 weeks may result in dependence, tolerance and  
withdrawal if stopped abruptly.Withdrawal symptoms can range from 
insomnia and anxiety to seizure and psychosis. Tolerance and the            
resultant withdrawal syndrome are due to the receptor down regulation  
and  GABAA receptor expression alteration. These effects can be 
minimized by gradual  reduction of dose of midazolam. 
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OVERDOSE: 
  Symptoms of midazolam overdose   include ataxia, dysarthria, 
nystagmus, slurred speech, somnolence, mental confusion, hypotension, 
respiratory arrest  vasomotor collapse,impaired motor functions,impaired 
coordination, impaired balance, dizziness,coma  and death. 
TREATMENT OF OVERDOSE: 
Flumazenil is a specific benzodiazepine antagonist which is given 
in the dose of 0.01-0.02 mg/kg. Repeat dose is given every 1 minute. The 
onset of  action occurs in 1 to 2 minutes and its effects last for  30-60 
minutes.  
Opioids and other sedatives are not antagonized. Prolonged  
observation is  necessary as resedation can occur in 1 hour. Flumazenil 
should not be used for routine dose reversal. Children may have 
exacerbations with Flumazenil. 
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TRICLOFOS 
STRUCTURE OF TRICLOFOS 
 
 
CHEMICAL STRUCTURE: 
2,2,2-trichloroethanol dihydrogen phosphate     C2H4Cl3O4P  
INTRODUCTION: 
Triclofos is a chloral sedative which is non barbiturate sedating 
drug which potentiates the central nervous system depression. It is a 
hypnotic drug which is used in disabling sleeplessness.It is always used 
as a second line drug in insomnia.Triclofos, being a prodrug is usually 
metabolized in the liver to trichloroethanol . It is long acting and may 
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cause sedation the next day also due to the slow action. It does not 
possess analgesic property. 
MECHANISM OF ACTION: 
Triclofos after being converted to trichloroethanol acts on the brain 
to cause sleep by shortening the time taken to fall asleep. There are no 
specific receptors on which triclofos acts. 
CLINICAL USES: 
Triclofos is used as a sedative for short procedures like dental  
procedures , used as premedication before major surgeries in paediatric 
age group. Triclofos is more palatable than its congener chloral hydrate 
and readily accepted  by children due to its sweet taste which is available 
as oral syrup. The dose is 50-75mg/kg orally. 
ONSET OF ACTION:   30-40 MINUTES 
DURATION OF ACTION:    6-8 HOURS 
CONTRAINDICATIONS: 
 Marked hepatic or renal impairment 
 Cardiac diseases 
 Patients with gastritis 
 Allergy to chloral hydrate 
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 Pregnancy 
 Breastfeeding 
SIDE EFFECTS: 
Cardiac arrhythmias, Jaundice, Albuminuria, Abdominal 
distension, Headache, Ataxia, Skin rashes, Confusion, Hallucination, 
Gastric irritation, Light headedness, Nightmares, Nausea, Vomiting, 
Diarrhoea, Constipation, Delirium, Flatulence, Dizziness, Dependence. 
DRUG INTERACTIONS: 
Alcohol, Antipsychotics, eg chlorpromazine, haloperidol , 
Baclofen, Barbiturates, eg phenobarbital, amobarbital , Benzodiazepines, 
eg diazepam, temazepam , MAOI antidepressants , Other sedatives eg 
zopiclone ,Sedating antihistamines such as chlorpheniramine, 
hydroxyzine, promethazine,  Opioid analgesics like morphine, codeine, 
Tricyclic and related antidepressants like amitriptyline, maprotiline. 
PRECAUTIONS: 
Triclofos should be used only for short term as it may cause 
dependence. It should be used with caution in elderly patients and in 
patients with alcohol or drug abuse. It may be used in patients with 
personality disorders with caution. 
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REVIEW OF LITERATURE 
1. Aruna Parameswari, et al2, in journal of anaesthesiology clinical 
pharmacology  2010;26(3) 340-344, had published a study “Sedative and 
anxiolytic effects of midazolam and triclofos oral premedication in 
children undergoing elective surgery: A comparison”. The aim of the 
study was to compare the efficacy of oral midazolam and oral triclofos as 
premedicants in children producing sedation, anxiolysis and acceptance 
of face mask. Forty children, ASA I, aged between 1 and 10 years posted 
for elective surgery were included in the study. As premedication, Group 
1 patients were given oral midazolam 0.5mg/ kg, and Group 2 patients 
were given 75mg/ kg of oral triclofos. The acceptance of premedication, 
level of sedation, level of anxiolysis and acceptance of face mask was 
assessed.In Group 1, 80% patients were awake, but calm, 5% patient 
were asleep during the assessment done 30 minutes after drug 
administration, while in Group 2, only 10% patients  were awake and 
calm, 65% patients of the patients were asleep (p value 0.000). In Group 
I, 50% patients never resisted the face mask and 40% patients had slight 
resistance whereas Group 2, 10% patients had no resistance to face mask 
and 55% patients had slight resistance. Face mask acceptance was better 
in Group 1 (p value of 0.014). 
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The author concluded that oral triclofos when given in the dose of 
75mg/kg produces better sedation and anxiolysis compared to oral 
midazolam 0.5mg/kg, but acceptance of face mask was better with 
midazolam. The limitations of triclofos were the longer time for the onset 
of action , peak effect and also the drowsiness it produces. 
2.JULIET D. BOYD AND MARGARET L. M. MANFORD6, in a 
study on “PREMEDICATION IN CHILDREN  A Controlled Clinical 
Trial of Oral triclofos and Diazepam” in the British journal of anaesthesia 
May 1973, 45, 501-506, tried to compare a hypnotic triclofos with a 
tranquiliser diazepam for premedication in children before minor ENT 
procedures. Children aged 2-9 years  were included in the trial. Two 
matching syrups were made  to contain optimum doses of diazepam and 
triclofos and labelled A and B and allocated on a random basis. The code 
remained in a sealed envdope until the trial completion and the results 
analysed. The constitution of the syrups was such that  a child received 
either 0.2 mg/kg of diazepam or 71 mg/kg of triclofos, 2 hours before 
induction of anaesthesia. atropine sulphate 0.03 mg/kg was added to the 
syrup. The children were monitored preoperatively and postoperatively. 
Children asleep or drowsy were given an inhalation induction and those 
awake given an intravenous injection. Post- operative analgesia  provided 
by intramuscular injection of dihydrocodeine tartrate 1-1.25 mg/kg.It 
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concluded that triclofos was better than diazepam in suppressing the 
salivary secretions and general behavior in the procedure room. 
3.Sujata chaudhry, et al1, in journal of anaesthesiology clinical 
pharmacology jan-march 2014,volume 30, issue 1 53-58, did a study 
named “Is midazolam superior to triclofos and hydroxyzine as 
premedicant in children?”  The study was done to compare the efficacy of  
the drugs midazolam, triclofos and hydroxyzine when used as 
premedication in children  who are undergoing lower abdominal 
surgeries.  
Sixty ASA PS I or II patients,  who are in the age group 2-8 years , 
scheduled for elective lower abdominal surgery were included in 
thestudy. The patients randomly divided into 3 groups M, T and H of 20 
children each and received midazolam 0.5 mg/kg, triclofos 75 mg/kg and 
hydroxyzine 0.5 mg/kg respectively, orally 60 min before surgery. The 
drug acceptability, sedation level, anxiety levels during parent separation 
and on  face mask application were assessed.  
  The acceptance of  the drugs midazolam and hydroxyzine were 
found to be better than triclofos. Hydroxyzine produced lesser sedative 
effect as compared to both midazolam and triclofos without major 
adverse effects. It was concluded in the study that midazolam is a better  
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premedicant when the  sedation, anxiolysis and safety  are compared to 
that of  triclofos or hydroxyzine .Triclofos  proved as  an acceptable 
alternative whereas  hydroxyzine was not proved as a good  premedicant  
according to this study. 
4. L. SAARNIVAARA,  et al17, in a study published in British journal of 
anaesthesia 1988 (61) 390-396, “COMPARISON OF CHLORAL 
HYDRATE AND MIDAZOLAM BY MOUTH AS PREMEDICANTS 
IN CHILDREN UNDERGOING OTOLARYNGOLOGICAL 
SURGERY”  gave Chloral hydrate in the doses of  25, 50 or 75 mg /kg or 
midazolam 0.4, 0.5 or 0.6 mg/ kg,  orally in combination with atropine 
0.03 mg /kg, to 248 children.  Chloral hydrate though was less palatable 
than midazolam, the anxiolytic effect in the dose 75 mg/ kg was good in 
children  < 5 yr, whereas the other two doses of chloral hydrate, and all 
the doses of midazolam, had provided only fair anxiolysis. In older 
children ,all doses of  both the premedicants proved as good anxiolytics. 
The antisialagogue effect was satisfactory   in 83-90% of each group. 
Restlessness  was observed 20 min after extubation, in 15-25% of the 
younger children premedicated with chloral hydrate 25 mg/ kg or with 
midazolam 0.4 or 0.6mg/kg. The study  concluded  that  midazolam 
should be given at a dose of 0.5 mg/kg in children younger <5 years and 
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0.4-0.5 mg/kg for older children and that chloral hydrate is not 
recommended as it is bitter to taste and unpalatable for children. 
5.Shabbir A, et al,8 published a study on “Comparison of oral 
midazolam and triclofos  for conscious sedation of uncooperative 
children” in the journal of clinical paediatric dentistry 2011, volume 36, 
number 2 189-196. The aim of the study was to compare the safety and 
efficacy of two orally administered sedative drugs triclofos 70 mg/kg and 
midazolam 0.5 mg/kg in paediatric dental patients. The conclusion was 
oral midazolam when used in a dose of 0.5 mg/kg is more effective than 
triclofos in regulating the behavior of children during the procedure. 
6.Bhatnagar S, et al20, in JOURNAL OF INDIAN SOCIETY OF 
PEDODONTICS AND PREVENTIVE DENTISTRY,  Apr - Jun 2012 , 
Issue 2 , Vol 30 109-114 , had published a study on “Comparison of oral 
midazolam with oral tramadol, triclofos and zolpidem in the sedation of 
pediatric dental patients: An in vivo study”. The aim of the study was to 
compare the effects of oral midazolam with oral tramadol,oral triclofos 
and oral zolpidem to produce conscious sedation in paediatric patients 
coming for dental procedures. 60  children who reported to the 
department, who were anxious and fearful ,were given conscious sedation 
for the accomplishment of dental treatment.They were randomly assigned 
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to four groups. Statistical analysis done using Kruskal Wallis Test and 
decision criterion was to reject the null hypothesis if the P -value < 0.05. 
The observation was that there was a statistical significant difference in 
median scores  for the level of sedation between the different groups                  
( P < 0.001). 
  The study concluded that midazolam 0.5mg/kg is the most 
effective drug for conscious sedation in paediatric dental patients. 
Tramadol 2mg/kg gave results equivalent to midazolam and triclofos 
70mg/kg though had good results during the procedure, the effect was not 
comparable with midazolam. Zolpidem though a good hypnotic did not 
produce the expected level  of  sedation. 
7.Razieh Fallah, et al14, in a study “Oral Chloral Hydrate vs. 
Intranasal Midazolam for Sedation During Computerized Tomography”  
published in the Indian Paediatrics, 2013, 50, 233-235,  aimed to compare 
the efficacy and safety of oral chloral hydrate with intranasal midazolam 
when used as sedative in paediatric age group for performing 
computerized tomography of  brain. They concluded that oral chloral 
hydrate is more effective than intranasal midazolam in sedating the 
uncooperative children presenting for CT scan of the brain. 
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8. Singh N, et al,24  in a study in the Journal of Clinical Pediatric 
Dentistry 2002 Winter;26(2),161-164, “A comparative evaluation of oral 
midazolam with other sedatives as premedication in pediatric dentistry” 
evaluated the efficacy and safety of oral midazolam as a sedative 
compared with other older agents like triclofos and promethazine in 
paediatric dentistry. The study was conducted on ninety children in the 
age group of 3-9 years  of ASA 1 requiring some short dental procedure. 
The patients were randomized into three study groups, on the basis of the 
drugs to be administered. After administration of drugs, the effects were 
evaluated in terms of onset of action, sedative effect, ease of treatment 
completion, recovery time and postoperative amnesia. The study 
concluded that oral midazolam is the best drug out of all the three as a 
sedative in terms of safety, efficacy, recovery and postoperative amnesia. 
9. ARATHI PAPINENI, et al,15 in International journal of 
Paediatric dentistry 2014, 24, 2-14, published a study on “Safety of oral 
midazolam sedation use in paediatric dentistry: a review”. The study 
aimed at evaluating the side effects and other adverse outcomes when 
oral midazolam was used for behavior management  in paediatric 
dentistry.  A review of published literature relating to the safety and side 
effects of oral midazolam  used in paediatric dental procedures was done. 
Both randomized controlled trials and non-randomised studies were 
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assessed. The side effects reported were recorded and classiﬁed as either 
signiﬁcant or not. The percentage prevalence of signiﬁcant or minor side 
effects per episode of treatment was calculated. Sixteen papers in the 
randomised controlled trials met the inclusion criteria.The side effects 
recorded were not considered as signiﬁcant. Minor side effects were 
reported (14%), with nausea and vomiting being the most frequently 
recorded (6%). 11 papers of non-randomised studies were also included. 
No signiﬁcant side effects  recorded.Minor side effects were recorded 
(8%), with paradoxical reaction being the most common at 3.8%. The 
author concluded that significant and major side effects were rare and 
minor events may occur, but the precise figure of it could not be achieved 
due to a poor reporting of such events. 
10.K. E. Wilson,et al,16 in British dental journal, April 2002, 
volume 192, no 8, 457-462, published  “A study of the effectiveness of 
oral midazolam sedation for orthodontic extraction of permanent teeth in 
children: a prospective, randomised, controlled, crossover trial”. The aim 
of the study was to assess the effectiveness , safety and acceptability of 
oral midazolam as a sedative when used for orthodontic extraction of 
permanent teeth in children. 26 children of age 10 – 16 years (ASA I), 
referred for orthodontic extraction of premolar or canine teeth under 
sedation, were included in the study. Each child had two treatment 
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sessions for the extraction of equivalent teeth on opposite sides of the 
mouth. Each subject was sedated with either oral midazolam (0.5 mg/kg) 
or nitrous oxide and oxygen (30%/70%) at  first visit and the alternative 
form at second visit. At each visit two teeth were extracted, one upper 
and one lower. Heart rate, arterial oxygen saturation, respiration rate, 
sedation and behavioural scores were recorded every five minutes. 
Overall behaviour, patient acceptance and patient satisfaction were 
recorded at the end of treatment. Out of the 26 children  in the study  12 
were males and 14 were females. The mean age was 12.5 years. The 
mean heart rate and respiratory rate in both groups were similar, within 
acceptable clinical limits. The lowest mean arterial oxygen saturation 
levels for nitrous oxide and midazolam sedation were 97.7% and 95.0% 
respectively. Though midazolam had caused  a greater oxygen 
desaturation, the range  was within safe limits for conscious sedation. The 
mean  sedation level was greater in the midazolam group compared with 
the nitrous oxide group . 88% of patients were prepared to have  oral 
midazolam sedation again and 65% actually preferred oral midazolam to 
nitrous oxide sedation. The study concluded that oral midazolam in the 
dose of 0.5 mg/kg appeared to be safe and effective form of sedation in 
children in the paediatric age group coming for dental procedures. 
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11.Saad A Sheta, et al,36 in the International journal of paediatrics 
2009, compared different doses of oral midazolam for premedication in 
paediatric age group. The doses of 0.5mg/kg,0.75mg/kg and 1mg/kg were 
observed for effectiveness in anxiolysis during parental separation and 
venepuncture and found that 0.75mg/kg oral midazolam as effective and 
acceptable dose as premedication and does not alter recovery time after 
general anaesthesia. 
12.Thomas R Vetter38, in the  journal of clinical anaesthesiology, 
January-february  1993,volume 5, issue 1,58-61, by a study “ A 
comparison of  midazolam, diazepam and placebo as oral premedicants in 
younger children” concluded that neither midazolam nor diazepam is 
necessary in children < 6 years and the routine use of premedication is 
not necessary in this age group. Premedication should be given based on 
the selective children at risk and with psychological imbalances. 
13.Luz María Gómez B12 , et al, in Colombian journal of 
anaesthesiology 2013 41(1) 4-9  have published a study on “ Efﬁcacy of 
anesthetic premedication in pediatric patients using oral midazolam and 
acetaminophen. Observational study”. A prospective descriptive 
observational study was conducted to analyse the efficacy of the 
premedication with a mix of midazolam and acetaminophen, sedation – 
anxiety scores were given and the parent separation score and mask 
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acceptance score were analysed. 216 children ASA PS I or II, scheduled 
for procedures that required general anesthesia. Anxiety-sedation scales  
(modiﬁed Yale scale and RASS), and tolerance to parent separation were 
assessed. 
The RASS scale  showed that 92% of the patients were at an 
adequate  sedation level  to tolerate the facemask  induction, while 86% 
of patients tolerated the separation from their parents. This study 
concluded that midazolam and acetaminophen proved effective as 
premedication in children and reduced the anxiety in children at the time 
of parent separation and also acceptance of the inhalation anaesthetic  
induction in a better way, thus improving the whole experience both for 
the children as well as the parents. 
14.Chandni Sinha,13 et al, in journal of anaesthesiology clinical 
pharmacology had published a study on “Comparative evaluation of  
midazolam and butarphanol as oral premedication  in paediatric patients”. 
The aim of the study was to compare the efficacy of oral midazolam in 
the dose of 0.5 mg/kg with oral butarphanol in the dose of 0.2mg/kg with 
regards to sedation, anxiolysis, rescue analgesic requirement and recovery 
profile. In this double blinded study, 60 pediatric patients of ASA class I 
and II inthe age group of 2–12 years posted for elective surgery were 
randomized to receive either oral midazolam (group I) or oral 
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butorphanol (group II) 30 min before induction of anesthesia. The 
children evaluated for levels of sedation and anxiety at the time of parent 
separation , venepuncture, and at  facemask application for induction of 
anesthesia. Rescue  analgesic requirement, postoperative recovery, and 
complications were also recorded.   Butorphanol showed better sedation 
level  than oral midazolam but the anxiolysis at parent separation of 
children were comparable. Midazolam was a better anxiolytic during 
venepuncture and  on facemask application. Butorphanol  reduces the  
need for supplemental analgesics perioperatively without  increase in the 
side effects. The author had concluded that Butorphanol had better 
sedation levels than oral midazolam but had  comparable anxiolysis at 
separation of children from parent  and also proved that midazolam as a 
better anxiolytic  on venepuncture and facemask application. 
Butorphanol demonstrated additional analgesic property and reduced the 
need for supplemental  analgesics without increase in side effects. 
15. Mohamed A Daabiss and Mohamed Hashish ,9 published a 
study in the British journal of medical practitioners December 2011, 
volume 4, number 4, named “Dexmedetomidine versus ketamine 
combined with midazolam: a comparison of anxiolytic and sedative 
premedication ”. The aim of the study is to evaluate the efficacy of  oral 
dexmedetomidine  as a hypnotic and anxiolytic when compared with oral 
ketamine and midazolam for paediatric premedication. 66 children posted 
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for elective surgical procedure were randomized into two groups, one 
group given dexmedetomidine 3mcg/kg and other group given 0.25 
mg/kg of oral midazolam with 2.5 mg/kg of ketamine. Drug acceptance 
score was recorded. Hemodynamic variables, sedation score and 
anxiolytic score recorded before sedation and then every 5 minutes post 
drug administration upto next 30 minutes.Parent separation score and 
mask acceptance score recorded at 30 minutes and results noted. The 
study concluded that premedication with midazolam/ketamine was 
superior to dexmedetomidine  providing haemodynamic stability and 
good parental acceptance although dexmedetomidine was accepted by 
the children. No significant side effects in both the medications and 
emergence from anaesthesia is comparable in both the groups. 
 16. NICOLE ALMENRADER,et al,7 in  Pediatric Anesthesia 
2007, 17,  1143–1149, in the study “Premedication in children: a 
comparison of oral midazolam and oral clonidine”  aimed at comparing 
the clinical effects of midazolam and clonidine.64 children were 
randomly assigned to receive either oral midazolam 0.5 mg/kg or oral 
clonidine 4 mcg/kg  prior to mask induction. Drug acceptance, 
preoperative sedation and anxiolysis, quality of mask acceptance, 
recovery proﬁle and parental satisfaction  evaluated.   The taste of oral 
clonidine  judged as signiﬁcantly better; 14%  children rejected oral 
midazolam. Onset of sedation  signiﬁcantly faster after premedication 
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with midazolam (30 ± 13.1 min) than with clonidine (38.5 ± 14.6 min), 
but level of sedation  signiﬁcantly better after clonidine. Quality of mask 
induction equally successful in both the groups.A trend towards an 
increased incidence of emergence agitation after midazolam 
premedication was noted  . Parental satisfaction signiﬁcantly higher in 
Clonidine group. The authors came to the conclusion that oral clonidine 
is superior to oral midazolam as a premedicant, mask acceptance 
comparable between both the groups but oral clonidine was better 
accepted by the children, had good sedation and smooth recovery and 
also better parent satisfaction. 
17. Ashu Mathai, et al,11 in Anaesthesia: Essays and researches 
January-june 2011, 5(1), 67-71, published the study “Preanesthetic 
sedation of  preschool children: comparison of intranasal midazolam 
versus oral promethazine” which aimed to analyse the efficacy of 
intranasal midazolam and orally administered promethazine in 
preanaesthetic sedative and calming effects in preschool children. 
Hundred preschool children undergoing elective surgery selected and 
sedated with either intranasal midazolam or oral promethazine syrup in 
the preoperative period. Levels of sedation till the period of mask 
placement for induction of general anesthesia was recorded.  The two 
groups had comparable heart rates, respiratory rates, sedation scores, and 
emotional scores at all points of assessment (P>0.05). But, intranasal 
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midazolam had a significantly shorter onset of sedation as well as time to 
reach maximal sedation (P<0.001). The conclusion of the study was that 
intranasal midazolam was equivalent to oral promethazine as a sedative 
and anxiolytic in preschool children undergoing surgery and that both 
the drugs are relatively easy to administer and do not require any 
additional equipment. The rapid onset and shorter duration to maximal 
sedation of intranasal midazolam  makes the drug useful, particularly in 
the outpatient setting.  
18. Fazi L, et al,25 published a study in Anaesthesia-Analgesia , 
2001 January;92(1):56-61, “A comparison of oral clonidine and oral 
midazolam as preanesthetic medications in the pediatric tonsillectomy 
patient” comparing the effects of oral clonidine 4 mcg/kg and oral 
midazolam 0.5 mg/kg on the preanaesthetic sedation and postoperative 
recovery profile during tonsillectomy in paediatric patients with or 
without adenoidectomy.In this double-blinded study design, 134 ASA PS 
I-II children aged 4-12 yr randomized to receive a combination of either 
clonidine and placebo  or placebo and midazolam  at 60-90 min and 30 
min, respectively,before the induction of anesthesia. Clonidine group 
children exhibited more intense anxiety on separation and during 
induction of anesthesia through a mask,  measured by the modified Yale 
Preoperative Anxiety Scores and also had significantly lower mean 
intraoperative arterial blood pressures, shorter surgery, anesthesia, and 
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emergence times, and a decreased need for supplemental oxygen during 
recovery compared with the midazolam group. However, the clonidine 
group had larger postoperative opioid requirements, maximum 
excitement and pain scores. No differences between the two groups in the 
times to discharge readiness, postoperative emesis, unanticipated hospital 
admission rates, postdischarge maximum pain scores, and 24 h analgesic 
requirementsd were noted. The percentage of  parents  completely 
satisfied with the child's preoperative experience was significantly higher 
in the midazolam group but no differences in parental satisfaction with 
the recovery period. The results were that under the conditions of this 
study, oral midazolam is superior to oral clonidine as a preanesthetic 
medication in this patient population.When comparing oral clonidine (4 
microg/kg) and midazolam (0.5 mg/kg) in children during tonsillectomy, 
clonidine group had greater preoperative anxiety and shorter surgery and 
anesthesia times, but required more postoperative analgesia whereas 
delayed recovery and discharge times did not differ. The study concluded 
that midazolam is superior to clonidine for premedication in paediatric 
tonsillectomy. 
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AIM OF THE STUDY    :                                                                                                        
To compare  the  sedative effects   of oral  triclofos with oral 
midazolam as a  premedicant  in paediatric  patients  for day care 
surgeries. 
PRIMARY OBJECTIVE: 
To compare the efficacy and safety of sedative effects of oral 
triclofos  with oral midazolam as a premedication for the day care 
surgeries done under general anaesthesia in the paediatric patients. 
SECONDARY OBJECTIVE: 
To compare the drug  compliance, parent separation score and the 
mask acceptance score of oral triclofos and oral midazolam. 
MATERIALS AND METHODOLOGY: 
Study design: 
This is a prospective double blinded randomized clinical trial done 
in the    Paediatric surgery theatre in Stanley medical college after getting 
approval    from the institutional ethical committee. A sample size of 150 
patients belonging to ASA PS 1 were randomly assigned into two groups 
namely  Group M and Group T.  
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Patients undergoing elective day care surgeries were enrolled in the   
study. Randomization was done by draw of  lots method. Midazolam and 
triclofos written on equal number of lots, 75 lots each. When the patient  
meets the criteria for study, the patient was asked to pick up a lot and the  
drug in the lot was given by the assistant professor of the theatre, who   
was not included the study. In the midazolam group, intravenous ampoule 
preparation of  preservative midazolam containing 5mg/ml was mixed 
with flavored  paracetamol syrup to make a volume of 0.5 ml/kg of that 
particular   patient.The assistant professor maintained a list of the names 
of the   patient, and the group to which they belong to. 
PATIENT SELECTION    : 
150 patients of ASA I of both sex undergoing day care surgeries 
under   general  anesthesia.  Sample size was 150 and was calculated with 
G*power 3.13 version with reference to parent study. 
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Analysis:  
Input: 
           Tail(s) = Two  
           Effect size d = 0.5484637  
           α err prob = 0.05 Power  
           (1-β err prob) = 0.90  
           Allocation ratio N2/N1 = 1  
Output: 
         Noncentrality parameter δ = 3.2678496  
         Critical t = 1.9770537  
         Df = 140  
         Sample size group 1 = 71  
         Sample size group 2 = 71  
       Total sample size = 142  
       Actual power = 0.9006717 
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INCLUSION CRITERIA    : 
                    ASA grade I  
                  Age 2 to 9 years 
                  Both Sex 
                  Undergoing   General  Anesthesia 
                  Undergoing  day care surgeries 
                  Children weighing less than or equal to 20 kg 
EXCLUSION CRITERIA     : 
 Clinically significant cardiovascular, neurologic, renal,             
hepatocellular or gastrointestinal diseases.  
 Patients with gastrointestinal disorder that affects the absorption of 
oral drug.  
 Allergy to the drugs studied. 
GROUPS     : 
Group M   : patients receiving   midazolam 0.5mg/kg (IV 
Midazolam containing 5mg/ml was mixed with flavored paracetamol  
syrup made to a total volume of  0.5 ml/kg) 
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 Group T   : patients receiving  oral triclofos 75mg/kg (each ml 
containing  100mg made to a volume of 0.5 ml/kg)     
MONITORING      : 
                                HR 
                                SpO2 
                                RR     
                                SEDATION SCORE 
MATERIALS    : 
 Commercially available oral triclofos syrup containing 
100mg/ml    
 Prepared oral midazolam formulation prepared by mixing 0.5 
mg/kg of midazolam taken from a preservative free midazolam 
ampoule 5mg/ml in which was added to flavored paracetamol 
syrup. 
 Drug filler 
 Syringe 
 22G intravenous cannula and IV Fluids 
 Drug for Caudal anaesthesia, 0.25% bupivacaine 
 Drug Inj atropine and Inj Fentanyl 
 All emergency drugs 
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METHODOLOGY    : 
150 patients with the average age of 2 –9 years undergoing  day 
care  surgeries under general anesthesia were randomized into two groups 
of 75  each by draw of lots method. A complete pre anaesthetic 
evaluation was done and the parents were explained about the effects, 
possible risks and complications of the premedicants in detail and 
informed consent was obtained. 
The child was shifted to the premedication room and oral 
Midazolam 0.5 mg/kg(iv drug containing 5mg/ml made into total volume 
of  0.5 ml/kg mixed with flavored paracetamol syrup) or oral Triclofos  
75mg/kg(each ml containing 100mg made to a volume of 0.5 ml/kg) was 
administered using a drug filler according to which group the child 
belongs to, by the assistant professor who was not involved in the study.  
Drug compliance scoring was done. 
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DRUG COMPLIANCE SCORE: 
1 Good Readily takes medicine 
2 Fair Accepts medicine with persuasion 
3 Poor Unwilling to take medicine or spits it out 
4 Very poor Refuses medicine 
 
             The level of sedation was assessed using the sedation score after 
10 minutes,  20 minutes, 30 minutes and 45 minutes of drug 
administration. 
RAMSAY  SEDATION SCORE 
        Level                 Characteristics 
          1 patient awake, anxious, agitated or restless 
          2 patient awake, co-operative, oriented and tranquil 
          3 patient drowsy, with response to commands 
          4 patient asleep, brisk response to glabella tap or loud 
auditory stimulus 
         5 patient asleep, sluggish response to stimulus 
         6 patient has no response to firm nail bed pressure or other 
noxious stimuli 
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         The child was  repeatedly assessed  for the level of sedation and was 
sent to operation theatre after 45 minutes of oral administration of 
premedicant. While shifting the child to the operating  room,  parent 
separation score was assessed.      
PARENT SEPARATION SCORE: 
       1 Calm and sleepy 
       2  Apprehensive but withdrawn from surroundings 
       3 Crying 
       4 Agitated but difficult to control 
 
On arrival in the operation  room, the patients’ baseline heart rate , 
SPO2, RR were recorded. Patients monitored with pulse oximetry ,  ECG 
and heart rate. 
Mask acceptance score was done in the operation room 
MASK ACCEPTANCE SCORE: 
    1 Poor Afraid, combative, crying 
   2 Fair Moderate fear of mask, not easily calmed 
   3 Good Slight fear of mask, easily calmed 
   4 Excellent Unafraid, cooperative, accepts mask easily 
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Child was induced with sevoflurane 8% with O 2/N 2O mixture at 4 litres 
of fresh gas flow at 50:50   ratio of  O2 /  N2O. 
Inj atropine 0.02mg iv in combination with Inj fentanyl 1 to 
2mcg/kg given intravenously. When the child was breathing smooth and 
regular, and when there was centrally fixed eye gaze, sevoflurane  dial  
settings stepped down to 2%.  
Anesthesia was maintained with sevoflurane 2% and caudal block     
given using 0.25% of bupivacaine  1ml/kg. Intra –operative HR ,SPO2 ,       
and RR are recorded every 5 min for  first 30 min and subsequently         
every 10 min intervals till the end of  surgery. Bradycardia  ( HR < 60 )         
persisting for > 2 min if occured, was to be treated with Inj .Atropine        
0.02 mg/kg IV boluses. Volatiles were discontinued at the end of         
Procedure. Ondansetron 0.2 mg/kg IV was given only if post operative 
nausea vomiting present. Sedation score, HR  , SPO2 and RR  were 
observed for  next 6 hours. 
Statistical analysis: The datas collected from the study, were 
statistically analysed. 
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The collected data was analysed with SPSS 16.0 version. To 
describe about  the data descriptive statistics frequency analysis, 
percentage analysis were used for categorical variables and for 
continuous variables the mean and S.D were used. 
To find the significance difference between the bivariate samples 
in Paired groups Wilcoxon signed rank test was used for skewed data and 
paired  sample t-test for the normal data & for Independent groups 
(Triclofos & Midazolam ) Mann-Whitney U test for skewed data and 
unpaired sample t-test for the normal data was used.  
For the multivariate analysis in the repeated measures the Friedman 
test was used. To find the significance in categorical data Chi-Square test 
was used. In all the above statistical tools the probability value .05 is 
considered as significant level.  
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OBSERVATION AND RESULTS: 
P-
Value Highly Significant at P ≤ .01 
 P-
Value  Significant at P ≤ .05 
 P-
value Not Significant at P > .05 
 
DEMOGRAPHIC VARIABLES 
 
GENDER DISTRIBUTION: 
 
          There was no significant difference between the two  groups in 
the gender distribution. Among the 75  children in Group M,  70 were 
male and 5 were   females whereas in Group T, 68 were males and 7   
were females. 
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Crosstab for gender distribution 
    
DRUGGIVEN 
Total Triclofos Midazolam 
SEX  F  Number 7 5 12 
 percentage  9.3% 6.7% 8.0% 
 
 
     
M  Number 68 70 138 
 percentage 90.7% 93.3% 92.0% 
 
 
     
Total   Number 75 75 150 
 percentage 100.0% 100.0% 100.0% 
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Chi-Square Tests for gender distribution 
  Value df 
Asymp. 
Sig. (2-
sided) 
Exact 
Sig. 
(2-
sided) 
Exact 
Sig. 
(1-
sided) 
Pearson 
Chi-Square 
.362 1 .547(not 
significant) 
    
      Continuity 
Correction 
         .091         1            .763     
 
Likelihood 
Ratio 
 
.364 
 
1 
 
.546 
    
Fisher's 
Exact Test 
      .765 .382 
          
No  of 
Valid 
Cases 
 
150 
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Frequency Table 
SEX 
   
Frequenc
y 
 
Percent 
 
Valid 
Percent 
 
Cumulative 
Percent 
 
Valid  F 12 
 
 
8.0 8.0 8.0 
 
M 138 
 
 
92.0 92.0 100.0 
 
 
 
 
Female, 12
Male, 138
Gender Distribution
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                     Cross tab for Age and Weight distribution: 
 
 
 
 
DRUG 
GIVEN 
 
N 
 
Mean 
 
Std.  
 
Deviatio
n 
 
Std. Error   
 
  Mean 
 
 
 
 
 
AGE 
 
 
 
  
Triclofos 
 
 
 
75 
 
4.2067 
 
2.10483 
 
.24304 
       
Midazola
m 
 
75 
 
3.9400 
 
2.12747 
 
.24566 
 
 
WEIGHT    
 
  IN  KG 
 
 
 
 
Triclofos 
 
75 
 
13.85 
 
3.283 
 
.379 
 
 
 
 
Midazola
m 
 
 
 
75 
 
13.68 
 
3.116 
 
.360 
 
 
                                   
Independent  Samples   Test 
   
Levene'
s Test 
for 
Equalit
y of 
Varianc t-test for Equality of Means 
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es 
F 
Si
g. t Df 
Sig. 
(2-
tailed
) 
Mean 
Differen
ce 
Std. 
Err
or 
Diff
eren
ce 
95% 
Confidence 
Interval of 
the 
Difference 
Low
er 
Upp
er 
 
 
AGE 
 Equal 
varian
ces 
assum
es 
.0
59 
.8
08 
.77
2 
148 .442 .26667 .34
557 
-
.416
22 
.949
56 
 
Equal 
varian
ces not 
assum
ed 
    .77
2 
147.
983 
.442 .26667 .34
557 
-
.416
22 
.949
56 
 
WEIG
HT IN 
KG 
 Equal 
varian
ces 
assum
ed 
.7
12 
.4
00 
.33
2 
148 .741 .173 .52
3 
-.859 1.20
6 
 
Equal 
varian
ces 
not 
assum
ed 
    .33
2 
147.
598 
.741 .173 .52
3 
-.859 1.20
6 
 
There is no statistical significance (p>.05)  
between the two groups in terms of age and weight of the patients. 
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Both groups were comparable in terms of age, the mean  
 
age being similar around 4 in both the groups.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 4
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
Triclofos Midazolam
Age
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In the weight distribution also, both the groups did not  
 
have any significant difference the mean weight being  
 
13.7 kg 
 
 
 
 
 
 
 
 
 
 
 
13.85
13.68
13
13.5
14
14.5
15
Triclofos Midazolam
Weight/kg
60 
 
CROSSTAB FOR DIAGNOSIS 
   
Frequenc
y 
Percen
t 
Valid 
Percen
t 
Cumulativ
e Percent 
Vali
d 
 
 
 
BALANOPOSTHITI
S 
 
 
1 
 
.7 
 
.7 
 
.7 
      ENCYSTED 
HYDROCELE OF 
CORD 
1 .7 .7 1.3 
  HYDROCELE 
 
25 
 
16.7 
 
16.7 
 
18.0 
  INGUINAL HERNIA 
 
14 
 
9.3 
 
9.3 
 
27.3 
 
     PENILE 
HYPOSPADIASIS 
2 1.3 1.3 28.7 
      PHIMOSIS 100 66.7 66.7 95.3 
 
 
POST 
PYELOLITHOTOM
Y 
 
1 
 
.7 
 
.7 
 
96.0 
 
     
PYELOPLASTY 
DONE 
1 .7 .7 96.7 
 
 
UMBLICAL 
HERNIA 
 
1 
 
.7 
 
.7 
 
97.3 
      UMBLICAL POLYP 1 .7 .7 98.0 
 
     
UNDESCENDED 
TESTIS 
2 1.3 1.3 99.3 
      VUJ CALCULUS 1 .7 .7 100.0 
 
     
Total 150 100.0 100.0   
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CROSS TAB FOR PROCEDURE 
   
Freque
ncy Percent 
Valid 
Percent 
Cumulativ
e Percent 
Vali
d 
  
ANATOMICAL 
REPAIR 
 
1 
 
.7 
 
.7 
 
.7 
 
 
CIRCUMCISION 
 
101 
 
67.3 
 
67.3 
 
68.0 
  CYSTOSCOPY 
 
1 
 
.7 
 
.7 
 
68.7 
 
     
DJ STENT 
REMOVAL 
 
2 1.3 1.3 70.0 
  EXPLORATION 
 
1 
 
.7 
 
.7 
 
70.7 
  HERNIOTOMY 
 
15 
 
10.0 
 
10.0 
 
80.7 
  ORCHIDOPEXY 
 
2 
 
1.3 
 
1.3 
 
82.0 
  PVSL 
 
25 
 
16.7 
 
16.7 
 
98.7 
 
 
URETHROPLAST
Y 
 
2 
 
1.3 
 
1.3 
 
100.0 
      Total 150 100.0 100.0   
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DRUG ACCEPTANCE SCORE FOR TRICLOFOS 
   Frequency Percent Valid Percent Cumulative Percent 
Valid   
1 
 
50 
 
66.7 
 
66.7 
 
66.7 
      
2 
 
 
21 28.0 28.0 94.7 
 
     
3 
 
 
 
4 5.3 5.3 100.0 
 
     
Total 75 100.0 100.0   
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                  DRUG  ACCEPTANCE SCORE  FOR  MIDAZOLAM 
   Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid  
 
 
1 
 
 
 
36 
 
48.0 
 
48.0 
 
48.0 
  
 
 
    
2 
 
 
35 46.7 46.7 94.7 
 
     
3 
 
 
 
 
4 5.3 5.3 100.0 
 
     
Total 
 
 
 
75 100.0 100.0   
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DRUG ACCEPTANCE SCORE 
              Ranks 
 
 
DRUG 
GIVEN 
 
             
N 
 
 
 
 
 
 
 
 
Mean 
Rank 
 
 
 
Sum of 
Ranks 
 
 
 
 
 
 
DRUG  
 
ACCEPTANC
E  
 
SCORE 
 
 
 
Triclofos 
 
75 
 
68.87 
 
5165.50 
     
Midazola
m 
75 82.13 6159.50 
 
    
Total 150     
 
 
 
Test Statistics 
  
Mann-
Whitn
ey U 
Wilcox
on W Z 
Asym
p. 
Sig. 
(2-
tailed
) 
 
DRUG 
ACCEPTA
NCE 
SCORE 
 
2315.5
00 
 
5165.5
00 
 
-
2.14
4 
 
.032 
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Score 1=good-readily takes medicine 
Score2=fair-accepts with persuasion 
Score3=poor-unwilling to take medicine  
 
Drug acceptance between the two groups showed a statistically 
significant  
 
(p=0.032<0.05) difference with triclofos better than midazolam. 
 
 
50
21
4
36 35
4
0
10
20
30
40
50
60
1 2 3
Drug acceptance score 
P=.032 ( significant)
Triclofos Midazolam
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The hemodynamic variables like the heart rate, respiratory rate and the  
 
oxygen saturation in the two groups were: 
 
 
 
DRUG 
GIVEN N Mean 
Std. 
Deviati
on 
Std. 
Error 
Mean 
HR/MIN Triclofos 75 110.97 18.698 2.159 
 
Midazolam 75 118.92 15.848 1.830 
RR/MIN Triclofos 75 21.44 3.523 .407 
 
Midazolam 75 22.24 3.377 .390 
 
     
SpO2 Triclofos 75 98.33 .553 .064 
      
 
Midazolam 75 98.16 .521 .060 
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The sedation scores noted at various time intervals showed a significant  
 
difference between the midazolam and triclofos with triclofos better than  
 
the midazolam 
2.0
3.0
4.1
4.9
2.0
2.9
3.8
4.3
0.0
1.0
2.0
3.0
4.0
5.0
6.0
10 Mins 2 Mins 30 Mins 45 Mins
Preoperative Sedation score 
Triclofos Midazolam
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There was no significant difference(p>0.05) at 10 minutes of drug 
administration between the two drugs. 
 
 
 
 
 
7
63
4
1
4
67
4
0
0
10
20
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40
50
60
70
80
1 2 3 4
Sedation score (10 min after drug) 
Triclofos Midazolam
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Crosstab for sedation score at 10 minutes after drug 
    
DRUGGIVEN 
Total Triclofos Midazolam 
 
 
 
 
 
Pre op 
Sedation  
 
Score 
10MIN 
1   
number 
 
7 
 
4 
 
11 
 
 
% within 
DRUGGIVEN 
 
9.3% 
 
5.3% 
 
7.3% 
 
     
2  number 63 67 130 
 % within DRUGGIVEN 
84.0% 89.3% 86.7% 
 
     
3  number 4 4 8 
     % within 
DRUGGIVEN 
5.3% 5.3% 5.3% 
 
     
4  number 1 0 1 
 % within DRUGGIVEN 
1.3% 0.0% .7% 
  
     
Total   number 75 75 150 
 % within DRUGGIVEN 
100.0% 100.0% 100.0% 
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Chi-Square Tests for sedation score at 10 min  
  Value df 
Asymp. 
Sig. (2-
sided) 
Pearson 
Chi-Square 
1.941a 3 .585 
Likelihood 
Ratio 
2.338 3 .505 
Linear-by-
Linear 
Association 
.043 1 .835 
No of Valid 
Cases 
150     
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Crosstab for sedation score at 20 minutes after drug 
    
DRUGGIVEN 
Total Triclofos Midazolam 
Pre op SS 
20MIN 
1  number 1 0 1 
 
% within 
DRUG 
GIVEN 
1.3% 0.0% .7% 
 
     
2  number 12 20 32 
 
% within 
DRUG 
GIVEN 
16.0% 26.7% 21.3% 
 
     
3  number 46 45 91 
 
% within 
DRUG 
GIVEN 
61.3% 60.0% 60.7% 
 
     
4  number 16 10 26 
     % within 
DRUG 
GIVEN 
21.3% 13.3% 17.3% 
  
     
Total   number 75 75 150 
 
% within 
DRUG 
GIVEN 
100.0% 100.0% 100.0% 
72 
 
Chi-Square Tests for sedation score 20 min 
after drug 
  Value df 
Asymp. 
Sig. (2-
sided) 
Pearson 
Chi-Square 
4.396 3 .222 
Likelihood 
Ratio 
4.816 3 .186 
Linear-by-
Linear 
Association 
2.323 1 .127 
N of Valid 
Cases 
150     
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There was no significant difference (p>0.05) at 20 minutes after drug  
administration between both the drugs. 
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Sedation score (20 mins after drug)
Triclofos Midazolam
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Crosstab for sedation  score at 30 minutes of drug administration 
    
DRUGGIVEN 
Total Triclofos Midazolam 
Pre op SS  
30MIN 
1   
Number 
 
1 
 
0 
 
1 
     % within  
DRUGGIVEN 
1.3% 0.0% .7% 
      2  Number 4 3 7 
 
 
% within  
DRUGGIVEN 
 
5.3% 
 
4.0% 
 
4.7% 
      3  Number 12 23 35 
 
  
% within  
DRUGGIVEN 
 
16.0% 
 
30.7% 
 
23.3% 
4   
Number 
 
28 
 
38 
 
66 
 
 
% within  
DRUGGIVEN 
 
37.3% 
 
50.7% 
 
44.0% 
      5  Number 30 10 40 
 
 
% within  
DRUGGIVEN 
 
40.0% 
 
13.3% 
 
26.7% 
      6  Number 0 1 1 
 
 
% within  
DRUGGIVEN 
 
0.0% 
 
1.3% 
 
.7% 
       Total   Number 75 75 150 
 
 
% within  
DRUGGIVEN 
 
100.0% 
 
100.0% 
 
100.0% 
75 
 
 
Chi-Square Tests for sedation score 30 min after 
drug 
  Value Df 
Asymp. 
Sig. (2-
sided) 
 
Pearson Chi-
Square 
 
17.115a 
 
5 
 
.004 
    
Likelihood 
Ratio 
18.418 5 .002 
 
Linear-by-
Linear 
Association 
 
4.961 
 
1 
 
.026 
 
No of Valid 
Cases 
 
150 
    
 
There was a significant difference (p<0.05) between the two groups at 30  
minutes of drug administration where 40% of the children in the triclofos  
group were in score 5 (asleep, sluggish response to stimulus) whereas in  
midazolam group it is only 13.3%. 
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Sedation score 30 mins after drug 
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Crosstab for sedation score after 45 minutes of drug 
    
DRUGGIVEN 
Total Triclofos Midazolam 
Pre op SS 
45MIN 
  
 
1 
  
Number 
 
1 
 
0 
 
1 
 
 
% within 
DRUGGIVEN 
 
1.3% 
 
0.0% 
 
.7% 
 
 
 
2 
  
Number 
 
2 
 
1 
 
3 
     % within 
DRUGGIVEN 
2.7% 1.3% 2.0% 
 
      3  Number 3 9 12 
 % within DRUGGIVEN 
 
4.0% 
 
12.0% 
 
8.0% 
 
      4  Number 15 41 56 
 % within DRUGGIVEN 
 
20.0% 
 
54.7% 
 
37.3% 
 
      5  Number 28 15 43 
     % within 
DRUGGIVEN 
 
37.3% 
 
20.0% 
 
28.7% 
 
      6  Number 26 9 35 
 
% within 
DRUGGIVEN 
 
34.7% 
 
12.0% 
 
23.3% 
Total   Number 75 75 150 
 
% within 
DRUGGIVEN 
 
100.0% 
 
100.0% 
 
100.0% 
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Chi-Square Tests for sedation score 45 min after 
drug 
  Value Df 
Asymp. 
Sig. (2-
sided) 
Pearson 
Chi-Square 
28.592a 5 .000 
Likelihood 
Ratio 
30.022 5 .000 
Linear-by-
Linear 
Association 
14.342 1 .000 
No of Valid 
Cases 
150     
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There was significant difference between the two groups(p=.000<.05), 
when sedation score at 45 minutes after drug administration was 
considered, with triclofos being better than midazolam as 34% of children 
in triclofos groupwere in score 6(no response to firm nail bed pressure or 
other noxious stimuli) compared to 12% of them in the midazolam group. 
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Sedation score 45 mins after drug
Triclofos Midazolam
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                                                   Test Statistics 
  
Mann-
Whitney U 
Wilcoxon 
W Z 
Asymp. 
Sig. (2-
tailed) 
     
Pre op SS10MIN 2743.500 5593.500 -.439 .585 
     Pre op SS20MIN 2430.000 5280.000 -1.647 .222 
     Pre op SS30MIN 2115.000 4965.000 -2.790 .004 
     Pre op SS45MIN 1679.000 4529.000 -4.463 .000 
 
PARENT SEPARATION 
SCORE 
 
2590.000 
 
5440.000 
 
-1.036 
 
.300 
 
MASK  ACCEPTANCE  
SCORE 
 
1616.500 
 
4466.500 
 
-4.924 
 
.000 
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PARENT SEPARATION SCORE FOR TRICLOFOS GROUP 
   Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid   
1 
 
56 
 
74.7 
 
74.7 
 
74.7 
 
 
2 
 
9 
 
12.0 
 
12.0 
 
86.7 
      3 7 9.3 9.3 96.0 
 
 
4 
 
3 
 
4.0 
 
4.0 
 
100.0 
 
 
Total 
 
75 
 
100.0 
 
100.0 
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PARENT SEPARATION SCORE FOR MIDAZOLAM 
GROUP 
   Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid   
1 
 
49 
 
65.3 
 
65.3 
 
65.3 
      2 16 21.3 21.3 86.7 
      3 8 10.7 10.7 97.3 
      4 2 2.7 2.7 100.0 
 
 
Total 
 
75 
 
100.0 
 
100.0 
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  Score 1-calm and sleepy                  
 
  Score 2-apprehensive but withdrawn from surroundings        
 
  Score 3-crying 
 
There was no significant difference between the two groups 
(p=0.3>0.05) as seen from the above tables, in the parent separation 
score. 
 
                
 
56
9
7
49
16
8
0
10
20
30
40
50
60
1 2 3
Parent  separation score
Triclofos Midazolam
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            MASK ACCEPTANCE SCORE FOR TRICLOFOS 
   Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid  
 
 
1 
 
5 
 
6.7 
 
6.7 
 
6.7 
  2 
 
2 
 
2.7 
 
2.7 
 
9.3 
      3 13 17.3 17.3 26.7 
  4 
 
55 
 
73.3 
 
73.3 
 
100.0 
  Total 
 
75 
 
100.0 
 
100.0 
  
 
 
 
MASK ACCEPTANCE SCORE FOR MIDAZOLAM 
 
   Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid   
1 
 
7 
 
9.3 
 
9.3 
 
9.3 
  2 
 
18 
 
24.0 
 
24.0 
 
33.3 
  3 
 
26 
 
34.7 
 
34.7 
 
68.0 
  4 
 
24 
 
32.0 
 
32.0 
 
100.0 
 
 
Total 
 
75 
 
100.0 
 
100.0 
  
                   
                  1-Poor-afraid,combative,crying 
                  2-Fair-moderate fear of mask, not easily calmed 
                  3-Good-slight fear of mask, easily calmed 
                  4-Excellent- unafraid,cooperative,accepts mask easily 
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There was a significant difference between the two 
drugs(p=0.00<0.05), in  terms of mask acceptance score with triclofos 
having excellent mask acceptance as depicted above. 73% of children in 
triclofos group have score  4(unafraid, cooperative, accepts mask easily) 
whereas only 32% of the  children in midazolam group have score 4. 
 
5
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Mask acceptance score
Triclofos Midazolam
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Paired Samples Statistics for triclofos 
   Mean N 
Std. 
Deviation 
Std. 
Error 
Mean 
Pair 1   
Preop   
HR 
 
110.97 
 
75 
 
18.698 
 
2.159 
 
 
Intraop  
HR 
 
111.68 
 
75 
 
16.789 
 
1.939 
 
      
Pair 2           Preop   
RR 
21.44 75 3.523 .407 
 
 
Intraop  
RR 
 
22.27 
 
75 
 
9.599 
 
1.108 
 
      
Pair 3  Pre op 
SpO2 
98.33 75 .553 .064 
 
 
Intraop 
SpO2 
 
98.24 
 
75 
 
.541 
 
.063 
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Paired Samples Test for triclofos 
   
Paired Differences 
t df 
Sig. 
(2-
taile
d) 
Mea
n 
Std. 
Deviati
on 
Std. 
Erro
r 
Mea
n 
95% 
Confidence 
Interval of 
the 
Difference 
Low
er 
Upp
er 
Pai
r 1 
 Preop HR 
– Intra op 
HR 
-
.707 
15.366 1.77
4 
-
4.24
2 
2.82
9 
-
.398 
7
4 
.692 
Pai
r 2 
 Preop RR 
– Intraop 
RR 
-
.827 
10.491 1.21
1 
-
3.24
0 
1.58
7 
-
.682 
7
4 
.497 
Pai
r 3 
 PreopSpO
2 - 
IntraopSp
O2 
.093 .720 .083 -.072 .259 1.12
3 
7
4 
.265 
 
 
As evident from the above statistical analysis, there is no 
significant variation of heart rate, respiratory rate and oxygen saturation 
intra operatively   after triclofos administration. 
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Paired Samples Statistics for midazolam 
   Mean N 
Std. 
Deviation 
Std. 
Error 
Mean 
Pair 1  Preop 
HR 
118.92 75 15.848 1.830 
      Intraop 
HR 
119.17 75 16.122 1.862 
 
      
Pair 2  Preop 
RR 
22.24 75 3.377 .390 
 
Intraop 
RR 
21.67 75 2.844 .328 
Pair 3  Preop 
SpO2 
98.16 75 .521 .060 
 
Intraop 
SpO2 
98.05 75 .399 .046 
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Paired Samples Test for midazolam 
   
Paired Differences 
T df 
Sig. 
(2-
tailed) Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper 
 
Pair 
1 
  
Preop 
HR – 
Intraop 
HR 
 
-.253 
 
10.743 
 
1.240 
 
-2.725 
 
2.218 
 
-.204 
 
74 
 
.839 
           
Pair 
2 
 Preop 
RR – 
Intraop 
RR 
.573 3.313 .383 -.189 1.336 1.499 74 .138 
 
Pair 
3 
  
Preop 
SpO2 
– 
Intraop 
SpO2 
 
.107 
 
.559 
 
.065 
 
-.022 
 
.235 
 
1.652 
 
74 
 
.103 
 
The above statistical analysis depicts that there is no significant 
variation of  heart rate, respiratory rate and oxygen saturation intra 
operatively  after  midazolam administration. 
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Crosstab for postop sedation score at 1 hour 
    
DRUGGIVEN 
Total 
Triclofo
s 
Midazola
m 
 
 
 
 
 
POST OP 
 
 
SEDATIO
N 
 
 SCORE at  
 
1HOUR 
 
1 
  
number 
 
2 
 
0 
 
2 
 
% within 
DRUGGIVE
N 
 
2.7% 
 
0.0% 
 
1.3% 
      2  number 3 2 5 
 
% within 
DRUGGIVE
N 
 
4.0% 
 
2.7% 
 
3.3% 
      3  number 5 15 20 
 
% within 
DRUGGIVE
N 
 
6.7% 
 
20.0% 
 
13.3% 
      4  number 45 46 91 
 
% within 
DRUGGIVE
N 
 
60.0% 
 
61.3% 
 
60.7% 
      5  number 20 11 31 
 
% within 
DRUGGIVE
N 
 
26.7% 
 
14.7% 
 
20.7% 
      6  number 0 1 1 
 
% within 
DRUGGIVE
N 
0.0% 1.3% .7% 
       Total   number 75 75 150 
 
% within 
DRUGGIVE
N 
100.0% 100.0% 100.0
% 
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Chi-Square Tests for sedation score 1 hour after surgery 
  Value df 
Asymp. 
Sig. (2-
sided) 
 
Pearson Chi-
Square 
 
10.824 
 
5 
 
.055 
 
Likelihood Ratio 
 
12.255 
 
5 
 
.031 
 
Linear-by-Linear 
Association 
 
.866 
 
1 
 
.352 
    No of Valid Cases 150   
 
There was no significant difference in the post operative sedation 
score at 1 hour between both the drugs(p=.055>0.05) 
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Crosstab for sedation score 2hrs postop 
    
DRUGGIVEN 
Total Triclofos Midazolam 
 
 
POST OP  
 
SEDATION  
 
SCORE AT  
 
2HRS 
 
 
1  NUMBER 3 0 3 
 
% within 
DRUG 
GIVEN 
4.0% 0.0% 2.0% 
 
 
 
 
     
2  NUMBER 4 7 11 
 
% within 
DRUG 
GIVEN 
5.3% 9.3% 7.3% 
 
 
     
3  NUMBER 33 46 79 
 
% within 
DRUG 
GIVEN 
44.0% 61.3% 52.7% 
 
 
     
4  NUMBER 33 17 50 
 
% within 
DRUG 
GIVEN 
44.0% 22.7% 33.3% 
 
 
     
5  NUMBER 2 5 7 
 
% within 
DRUG 
GIVEN 
2.7% 6.7% 4.7% 
 
 
 
     
Total   NUMBER 75 75 150 
 
% within 
DRUG 
GIVEN 
100.0% 100.0% 100.0% 
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Chi-Square Tests for sedation score 2 hours after surgery 
  Value df 
Asymp. Sig. (2-
sided) 
Pearson Chi-
Square 
12.363a 4 .015 
Likelihood Ratio 13.676 4 .008 
Linear-by-Linear 
Association 
.564 1 .453 
No of Valid 
Cases 
150     
  
There was significant difference between the two groups at 2 hours 
post op(p.015<0.05),with larger number of children still in higher levels 
of sedation in midazolam group compared to triclofos group. 
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Crosstab for postop sedation at 3 hrs 
   
DRUGGIVEN 
Total Triclofos Midazolam 
 
 
 
 
POST OP  
 
SEDATION  
 
SCORE  
 
3HRS 
 
 
1  NUMBER 3 1 4 
 
% within 
DRUG 
GIVEN 
4.0% 1.3% 2.7% 
 
 
 
 
     
2  NUMBER 16 19 35 
 
% within 
DRUG 
GIVEN 
21.3% 25.3% 23.3% 
 
 
     
3  NUMBER 43 45 88 
 
% within 
DRUG 
GIVEN 
57.3% 60.0% 58.7% 
 
 
     
4  NUMBER 13 9 22 
 
% within 
DRUG 
GIVEN 
17.3% 12.0% 14.7% 
 
 
     
5  NUMBER 0 1 1 
 
% within 
DRUG 
GIVEN 
0.0% 1.3% .7% 
 
 
 
     
Total   NUMBER 75 75 150 
 
% within 
DRUG 
GIVEN 
100.0% 100.0% 100.0% 
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Chi-Square Tests for sedation score 3 
hours after surgery 
  Value df 
Asymp. 
Sig. (2-
sided) 
Pearson 
Chi-Square 
3.030 4 .553 
Likelihood 
Ratio 
3.467 4 .483 
Linear-by-
Linear 
Association 
.013 1 .908 
N of Valid 
Cases 
150     
 
There was no significant difference between the two groups (p>0.05) in 
terms of postop sedation score at 3 hours. 
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Crosstab for post op sedation score at 4 hours 
    
DRUGGIVEN 
Total 
Triclofo
s 
Midazola
m 
 
 
 
POST OP  
 
SEDATIO
N  
 
SCORE AT  
 
4HRS 
 1   
NUMBER 
 
7 
 
4 
 
11 
 
% within 
DRUGGIVE
N 
9.3% 5.3% 7.3% 
 
 
     
2  NUMBER 27 39 66 
 
% within 
DRUGGIVE
N 
36.0% 52.0% 44.0% 
 
 
     
3  NUMBER 40 28 68 
 
% within 
DRUGGIVE
N 
53.3% 37.3% 45.3% 
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4  NUMBER 1 3 4 
 
% within 
DRUGGIVE
N 
1.3% 4.0% 2.7% 
 
 
     
5  NUMBER 0 1 1 
     % within 
DRUGGIVE
N 
0.0% 1.3% .7% 
 
 
 
     
Total   NUMBER 75 75 150 
 
% within 
DRUGGIVE
N 
100.0% 100.0% 100.0
% 
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Chi-Square Tests for sedation score 4 hours after 
surgery 
  Value Df Asymp. Sig. (2-sided) 
 
Pearson 
Chi-Square 
 
7.118 
 
4 
 
.130 
 
 
Likelihood 
Ratio 
 
 
7.584 
 
 
4 
 
 
.108 
    
 
Linear-by-
Linear 
Association 
 
 
.054 
 
 
1 
 
 
.816 
      
 
No of Valid 
Cases 
 
 
150 
  
 
As seen from the above table there is no significant difference      
(p=0.13>0.05)  noted between the two groups for postop sedation 
score at 4hrs. 
 
 
99 
 
Crosstab for sedation score at 5hrs postop 
    
DRUGGIVEN 
Total Triclofos Midazolam 
 
 
 
 
POST  
 
SEDATION  
 
SCORE AT  
 
5HRS 
 1   
NUMBER 
 
8 
 
5 
 
13 
 
% within 
DRUG 
GIVEN 
 
10.7% 
 
6.7% 
 
8.7% 
 
 
     
2  NUMBER 42 54 96 
 
% within 
DRUG 
GIVEN 
 
56.0% 
 
72.0% 
 
64.0% 
 
 
     
3  NUMBER 25 14 39 
 
% within 
DRUG 
GIVEN 
 
33.3% 
 
18.7% 
 
26.0% 
 
 
     
4  NUMBER 0 2 2 
     % within 
DRUG 
GIVEN 
 
0.0% 
 
2.7% 
 
1.3% 
        
Total   NUMBER 75 75 150 
 
% within 
DRUG 
GIVEN 
 
100.0% 
 
100.0% 
 
100.0% 
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Chi-Square Tests for sedation score 5 
hours after surgery 
  Value Df 
Asymp. 
Sig. (2-
sided) 
Pearson 
Chi-Square 
 
7.295a 3 .063 
 
Likelihood 
Ratio 
 
8.120 3 .044 
Linear-by-
Linear 
Association 
 
.294 1 .587 
No of Valid 
Cases 
150     
 
 
No significant difference was noted between the groups(p=0.063>0.05), 
when considering the postop sedation score at 5 hours. 
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Crosstab for sedation score 6 hrs postop 
    
DRUGGIVEN 
Total Triclofos Midazolam 
 
 
 
POST OP  
 
SEDATION  
 
SCORE  
 
6HRS 
 1   
NUMBER 
 
8 
 
16 
 
24 
 
% within 
DRUG 
GIVEN 
 
10.7% 
 
21.3% 
 
16.0% 
 
 
     
2  NUMBER 63 54 117 
 
% within 
DRUG 
GIVEN 
 
84.0% 
 
72.0% 
 
78.0% 
 
 
     
3  NUMBER 4 4 8 
 
% within 
DRUG 
GIVEN 
 
5.3% 
 
5.3% 
 
5.3% 
 
 
     
4  NUMBER 0 1 1 
 
% within 
DRUG 
GIVEN 
 
0.0% 
 
1.3% 
 
.7% 
Total    
NUMBER 
 
75 
 
75 
 
150 
 
% within 
DRUG 
GIVEN 
 
100.0% 
 
100.0% 
 
100.0% 
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Chi-Square Tests for sedation score 
6hrs after surgery 
  Value Df 
Asymp. 
Sig. (2-
sided) 
Pearson 
Chi-Square 
4.359a 3 .225 
Likelihood 
Ratio 
4.798 3 .187 
Linear-by-
Linear 
Association 
1.031 1 .310 
No of Valid 
Cases 
150     
 
No significant difference(p=0.225>0.05) in postop sedation score at 6 hrs 
between the two groups 
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FREQUENCY TABLE FOR ADVERSE  EFFECTS  
   Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid  LARYNGOSPASM 2 1.3 1.3 4.0 
 
 
NIL 
 
140 93.3 93.3 97.3 
 
RESPIRATORY 
DEPRESSION 
1 .7 .7 98.0 
 
SHIVERING 
 
1 .7 .7 98.7 
 
VOMITING 
 
2 1.3 1.3 100.0 
 
Total 
 
150 100.0 100.0   
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             Crosstab for adverse effects 
    
DRUGGIVEN 
Total 
Triclof
os 
Midazola
m 
 
 
 
 
 
ADVERS
E 
EFFECTS 
      
 
      LARYNGOSPA
SM 
 NUMBER 0 2 2 
 
% within 
DRUG 
GIVEN 
 
0.0% 
 
2.7% 
 
1.3% 
 
      NIL  NUMBER 71 69 140 
 
% within 
DRUG 
GIVEN 
 
94.7% 
 
92.0% 
 
93.3% 
 
      RESPIRATORY 
DEPRESSION 
 NUMBER 1 0 1 
 
% within 
DRUG 
GIVEN 
 
1.3% 
 
0.0% 
 
.7% 
 
  
    
SHIVERING  NUMBER 1 0 1 
 
% within 
DRUG 
GIVEN 
 
1.3% 
 
0.0% 
 
.7% 
 
      VOMITING  NUMBER 1 1 2 
 
% within 
DRUG 
GIVEN 
 
1.3% 
 
1.3% 
 
1.3% 
       Total   NUMBER 75 75 150 
 
% within 
DRUG 
GIVEN 
 
100.0% 
 
100.0% 
 
100.0
% 
 
105 
 
 
Chi-Square Tests for adverse effects 
  Value df 
Asymp. 
Sig. (2-
sided) 
 
 
Pearson 
Chi-Square 
 
 
5.029 
 
 
5 
 
 
.412 
     
 
Likelihood 
Ratio 
 
 
 
6.620 
 
 
 
5 
 
 
 
.250 
 
 
 
 
No of Valid 
Cases 
 
 
 
 
150 
    
 
 
No significant difference in the occurrence of adverse effects in the 
two  groups as evident from p value=0.412>0.05.(not significant). 
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ANALYSIS  OF  STATISTICAL DATA: 
 
S.NO 
 
PARAMETER ASSESSED 
 
P VALUE 
SIGNIFICANT 
OR NOT 
1 Age 0.442     No 
2 Gender 0.547     No 
3 Weight 0.741     No 
4 Drug acceptance score 0.032     Yes 
5 Sedation score at 10 min 0.585     No 
6 Sedation score at 20 min 0.222     No 
7 Sedation score at 30 min 0.004     Yes 
8 Sedation score at 45 min 0.000   Yes 
9 Parent separation score 0.300   No 
10 Mask acceptance score 0.000   Yes 
11 Postop sedation score at 1hr 0.055   No 
12 Postop sedation score at 2hrs 0.015   Yes 
13 Postop sedation score at 3hrs 0.553   No 
14 Postop sedation score at 4hrs 0.130   No 
15 Postop sedation score at 5hrs 0.063   No 
16 Adverse effects 
 
0.412 
 
  No 
 
107 
 
DISCUSSION: 
Premedication in children is necessary to allay fear and anxiety 
before surgery and provide a smoother anaesthesia for the children. The 
search for a perfect premedicant  has been on and continues. So we have 
done this study to find out a good premedication out of the ones widely 
used.We have chosen to compare oral midazolam and triclofos which is 
being used as sedative for short procedures. 
The sample size of 142 was arrived with G* power 3.13 version 
with reference to parent study, and 150 cases was taken into study 
accounting for any dropout from the study due to practical difficulties 
like spitting out of the drug, etc.   
ASA PS 1 cases were chosen so that there are no major side effects 
by the drug or by the co existing diseases. The maximum weight allowed 
in the study was 20 kg to avoid  giving large volume of drug as 
premedication. Luz Maria et al12, have accepted ASA 1 and 2 patients for 
their study on evaluating the efficacy of  oral midazolam with 
acetaminophen for premedication. Wilson et al16, selected  ASA 1 
patients for their study on the effectiveness of oral midazolam for 
sedation in orthodontic procedures. 
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The dose of the drug was chosen as Midazolam 0.5mg/kg based on the 
study  Premedication of  children with midazolam  by  Mc Millan, et al32  
which concluded that oral midazolam given at a dose of 0.5 mg/kg was 
effective at causing sedation without any side effects. Fazi et al25, in a 
study to compare oral midazolam and clonidine for sedation of paediatric 
tonsillectomy patients used midazolam as 0.5 mg/kg. Shabbir et al8, in 
their study for comparison of conscious sedation  between oral 
midazolam  and triclofos used midazolam 0.5 mg/kg orally   
The dose of  triclofos was 75mg/kg based on the studies of Aruna 
Parameswari et al2 and  Sujata Chaudhary et al1, where the dose of 75 
mg/kg proved effective in both the studies. R.K.Gupta et al18, in their 
study on oral premedication in children had used oral triclofos in the dose 
of 75mg/kg. Bhatnagar et al20, in their study on comparison of oral 
midazolam with oral tramadol, triclofos and zolpidem  for sedation of 
paediatric dental patients  used  triclofos in the dose of 70mg/kg. 
The  usage of intravenous preparation of midazolam given orally 
mixed with a vehicle in our study to make it palatable and the fact that it 
is more reliable and effective than the commercially available oral 
formulation is supported by the study of  Brosius KK et al26 ,where the 
study proved that the iv preparation mixed with a vehicle produced a 
109 
 
more reliable sedation and higher plasma level of the drug compared to 
the equivalent  dose of the commercially available preparation. The drugs 
were given 45 minutes prior to induction time to match the peak effect of 
both the drugs in common2. 
The age distribution was comparable in our study, with the mean 
age being 4 years in both the groups and insignificant difference was 
noted(p=0.442) between the two groups. The gender difference between 
the midazolam and triclofos group was not significant  (p=0.547)  and the 
weight in kilograms of  the children in both the groups  was on an 
average 13.7 kg  without any significant difference (p=0.741).  This is in 
favour  that  any difference between the two groups in demographic 
profiles would  be purely by chance. 
The  aim of our study was to compare the sedative effects of oral 
midazolam and oral triclofos.  Triclofos was better in our study as a good 
sedative, with the sedation score significantly better(p=0.000) with 
triclofos than midazolam which is in concordance with Aruna 
Prameswari et al study where they concluded triclofos as a better sedative 
and anxiolytic than midazolam. 
 The drug acceptance was better with triclofos shown by a  
statistically significant difference(p=0.032) in contrary to the study by 
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Sujata Chaudhary et al1 in which greater percentage of children were 
complaint with midazolam than triclofos but with a statistically 
insignificant difference. Aruna Parameswari et al2, in the study for 
comparison of  sedative effects of triclofos and midazolam  had 80% of 
the patients in midazolam group accepted the drug whereas 20% resisted 
the drug, but  in triclofos group 75% accepted the drug and 25% resisted 
the drug but the difference between the two groups was not statistically 
significant. 
The difference in preoperative sedation scores at 10 
minutes(p=0.585) of drug administration was not significant. Of the 75 
children in the triclofos group, 63 were in the score 2(patient 
awake,cooperative, oriented and tranquil) and 67 out of 75 in midazolam 
group were in score 2. 
Sedation score at 20 minutes of  drug administration showed no 
significant difference (p=0.222) between the two drugs.In triclofos group 
46 children were in score 3(patient drowsy, with response to commands) 
and 45 children in midazolam group were in score 3. 
Whereas the sedation scores at 30 minutes of drug intake showed 
30 children (40%) in score 5(patient asleep, sluggish response to 
stimulus) in triclofos group, but the midazolam group had only 10 
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children(13%)  in score 5 , which means there is a statistically significant 
difference(0.004). 
The preoperative sedation score showed a highly significant 
difference  (p=0.000) at 45 minutes of drug administration with the 
triclofos group having 34% of the children in score 6(no response to firm 
nail bed pressure or other noxious stimuli) against midazolam group 
which had only 12% of children in score 6.     
So it was evident from the preoperative sedation scores , that 
triclofos produces  better sedation than midazolam  which is similar to the 
results of the study of Aruna Parameswari et al2, where only 5% of 
patients in midazolam group  after 30 minutes were asleep as compared to 
65% sedated patients after 90 minutes in the triclofos group,  showing a 
significant difference.  Bhatnagar et al20, in comparing oral midazolam 
with triclofos and two other drugs , triclofos had better sedation score 
when compared to midazolam.  
Mohamed et al9 , found that oral midazolam with ketamine 
provided high sedation levels after 30 minutes of administration when 
compared to dexmedetomidine in their study. Wilson et al16  in studying 
the effectiveness of oral midazolam sedation for paediatric orthodontic 
procedures, found  that the mean level of sedation to be greater for 
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midazolam when compared to nitrous oxide.  Singh et al24, found  
midazolam to be the best sedative among the three drugs(midazolam, 
triclofos, promethazine) for conscious sedation in paediatric dentistry. 
The parent separation score was comparable between the two 
groups in the present study(p=0.3).Sujata Chaudhary et al1, in their study 
also showed comparable parent separation score with both  midazolam 
and triclofos. Luz Maria et al12, in their study on efficacy of oral 
midazolam combined with acetaminophen showed that 86% of children 
were quiet at parent separation. 
The mask acceptance score was good with triclofos as compared to 
midazolam  (p=0.00) in our study. In contrary, Aruna parameswari, et al2, 
have depicted a better mask acceptance with midazolam in their study 
comparing 40 children with 20 in each group. Whereas Sujata Chaudhary 
et al1, had no difference in both the groups when comparing 20 children 
in the midazolam group with 20 in the triclofos group for mask 
acceptance. Nicole Almanrader et al7 , found no statistical difference 
between clonidine and midazolam for mask acceptance  with 86%  
satisfactory mask induction in  midazolam group and 83% in clonidine 
group. Mohamed et al9, study demonstrated better facemask acceptance at 
113 
 
induction in the midazolam ketamine group when compared to 
dexmedetomidine group. 
The postoperative sedation scores at 2 hours postoperative showed 
significant difference between the triclofos and midazolam (p=0.015), 
with midazolam showing greater percentage of the children in higher 
sedation levels but the post operative sedation scores at 1hour, 3 hours, 4 
hours , 5 hours and 6 hours showed no significant difference between the 
two groups. Sujata Chaudhary et al1, found no significant difference in 
the post operative recovery characteristics in the midazolam and triclofos 
group in their study. There was no significant difference in the recovery 
profile between the butorphanol and midazolam group in the study by 
Sinha et al13. No significant difference noted by Saarnivaara et al17  in the 
recovery scores between chloral hydrate and midazolam in children . 
The hemodynamic variables in the two groups were  mean heart 
rate   110.97(±18.6) in the triclofos group and  118.92(±15.8) in the 
midazolam group , mean respiratory rate was 21.44(±3.52) in triclofos 
group and 22.24(±3.37), mean oxygen saturation was 98.33(±0.553) in 
triclofos group and 98.16(±0.521) .The intraoperative hemodynamics did 
not show a significant variation from the  preoperative values in both the 
groups (p>0.05) There was no significant  variation  of   heart 
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rate(p=0.692), respiratory rate(p=0.497) and oxygen saturation(p=0.265) 
intra  operatively   after triclofos administration and also no  significant 
variation of   heart rate(p=0.839), respiratory rate(p=0.138) and oxygen 
saturation(p=0.103)  intra operatively  after    midazolam administration. 
Sujata Chaudhary et al1  have shown decrease in heart rate  and blood 
pressure in both the triclofos and midazolam groups after drug 
administration.  
The adverse effects  occurred were minimal  and were statistically 
insignificant(p=0.412). Laryngospasm occurred in 2 children in the 
midazolam ,  treated with 100% O2 ; vomiting occurred in 1child in each 
group, Inj.   Ondansetron given iv. One child in triclofos group had 
shivering. 
LIMITATIONS: 
The peak onset of action of the two drugs are not similar but the 
difference is only 10-15 minutes. As the study included only day care 
surgery, most of the children were males presenting with phimosis, hernia 
and hydrocele for surgery. The volume of drug in both the groups could 
not be kept constant as drug was administered on weight basis and the 
two drugs are available as different per millilitre doses. 
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Summary: 
        Demographic profiles were comparable between the two groups. 
Triclofos being more palatable, was better accepted by the children, 
produced excellent sedation after 45 minutes of drug administration than 
midazolam. The parent separation score was comparable between the two 
groups. The mask acceptance score was good with triclofos than  
midazolam. The postoperative recovery score was better with triclofos. 
 
Conclusion:            
      Based on our study “ Randomised clinical trial to compare the 
sedative effects of oral triclofos with oral midazolam as premedicants in 
children”, we find Triclofos  is a better and safe sedative   than 
midazolam given as premedicant  in paediatric patients. 
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PROFORMA: 
NAME:     AGE/SEX:    IP 
NO.: 
DATE:     Wt.:    
 GROUP: 
DIAGNOSIS: 
SURGERY: 
BRIEF HISTORY: 
COEXISTING ILLNESS: 
EXAMINATION: 
 PR:     CVS: 
 BP:     RS: 
 RR:      
INVESTIGATIONS: 
 Hb:         BLOOD UREA:  
  
 URINE           ALB:    SUGAR:   
    
       SUGAR:    Sr. CREATININE: 
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ANESTHESIA DETAILS: 
PREMEDICATION: 
INDUCTION 
MAINTENANCE 
PARAMETERS OBSERVED 
 
PRE OP SEDATION SCORE 
10 
min  
20 
min 
30 
min 
40 
min 
45 
min 
     
 
 
DRUG 
COMPLIA
NCE 
SCORE 
SEDATI
ON 
SCORE 
AT 45 
MIN 
PARENT 
SEPARAT
ION 
SCORE 
MASK 
ACCEPTA
NCE 
SCORE 
MEA
N 
HR 
MEA
N 
SpO
2 
MEA
N 
RR 
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Hemodynamic  parameters during surgery and post op: 
 5 
min 
10 
min 
15 
min 
20min 25 
min 
30 
min 
35 
min 
40 
min 
45 
min 
50 
mi
n 
55 
min 
60
min 
HR             
RR             
SpO2             
 
 
POST OP SEDATION SCORE 
1 Hr 2 Hr 3 Hr 4 Hr 5 Hr 6 Hr 
      
 
 
 
